Navigation

Investiment.io
Financial analysis platform

AbbVie Inc.

ABBV โ€ข NYSE

$294.55
โ–ผ0.48 (0.16%)โ€ข REGULAR

AbbVie Inc.

$294.55
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ’ง

Cash Flow StatementABBV

Cash Flow Summary

Key cash flow metrics and liquidity indicators for ABBV

๐Ÿ”„
Operating Cash Flow
$19,030,000
(in thousands)
๐Ÿ’ฐ
Free Cash Flow
$17,816,000
(in thousands)
๐Ÿ—๏ธ
Capital Expenditures
-$1,214,000
(in thousands)
๐Ÿ“ˆ
Net Change in Cash
-$295,000
(in thousands)

Cash Flow Analysis

Analyze operating, investing, and financing cash flows over time

Period:annual

Select Metrics to Compare (4 selected)

Net Operating Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$6.50B$13.00B$19.50B$26.00B-18%-9%0%+9%+18%
  • Net Operating Cash Flow
  • Net Operating Cash Flow YoY Growth

Free Cash Flow Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$6.50B$13.00B$19.50B$26.00B-20%-10%0%+10%+20%
  • Free Cash Flow
  • Free Cash Flow YoY Growth

Capital Expenditures Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-1.40B$-1.20B$-1.00B$-800.00M$-600.00M-36%-24%-12%0%+12%
  • Capital Expenditures
  • Capital Expenditures YoY Growth

Net Change in Cash Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$-8.00B$-4.00B$0.00K$4.00B$8.00B-350%0%+350%+700%+1050%
  • Net Change in Cash
  • Net Change in Cash YoY Growth